Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 12 (December)

1. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.
   Br J Surg, 92(12): 1508-12. [Abstract] [Full-text]
2. 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells.
   Cancer Chemother Pharmacol, 57(2): 165-70. [Abstract] [Full-text]
3. Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.
   Cancer Chemother Pharmacol, 57(2): 185-90. [Abstract] [Full-text]
4. Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo.
   Cancer Immunol Immunother, 55(1): 31-8. [Abstract] [Full-text]
5. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.
   JAMA, 294(22): 2872-8. [Abstract] [Full-text]
6. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
   Cancer, 104(12): 2830-6. [Abstract] [Full-text]
7. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
   Clin Cancer Res, 11(24): 8773-81. [Abstract] [Full-text]
8. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
   Clin Cancer Res, 11(24): 8737-44. [Abstract] [Full-text]
9. Expression of cytokeratin-20 in pancreatic cancer: an indicator of poor outcome after R0 resection.
   Surgery, 139(1): 104-8. [Abstract] [Full-text]
10. Duct-to-mucosa pancreaticogastrostomy is a safe anastomosis following pancreaticoduodenectomy.
    Br J Surg, 93(1): 73-7. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.